Home

DENTSPLY SIRONA Inc. - Common Stock (XRAY)

15.59
-0.40 (-2.50%)

Dentsply Sirona Inc is a global leader in the dental industry, specializing in the manufacturing and distribution of a wide range of dental products and technologies

The company provides innovative solutions for dental professionals, including equipment, instruments, and materials used in various dental procedures, such as restorative, preventive, and orthodontic care. Dentsply Sirona focuses on improving patient outcomes through advancements in dental technology, offering products that enhance treatment efficiency and effectiveness. By catering to dental professionals worldwide, the company plays a pivotal role in enhancing oral health and clinical practice standards.

SummaryNewsPress ReleasesChartHistoricalFAQ
Dental Equipment & Technology Stocks Q4 In Review: Henry Schein (NASDAQ:HSIC) Vs Peers
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Henry Schein (NASDAQHSIC) and the best and worst performers in the dental equipment & technology industry.
Via StockStory · March 4, 2025
Expert Outlook: Dentsply Sirona Through The Eyes Of 9 Analystsbenzinga.com
Via Benzinga · February 28, 2025
Dentsply Sirona (NASDAQ:XRAY) Misses Q4 Sales Targets, Stock Drops
Dental products company Dentsply Sirona (NASDAQXRAY) missed Wall Street’s revenue expectations in Q4 CY2024, with sales falling 10.6% year on year to $905 million. The company’s full-year revenue guidance of $3.55 billion at the midpoint came in 5% below analysts’ estimates. Its non-GAAP profit of $0.26 per share was 40.1% below analysts’ consensus estimates.
Via StockStory · February 27, 2025
Dentsply Sirona Q4: Earnings Miss, 10% Sales Drop, Soft 2025 Outlook And Morebenzinga.com
Dentsply Sirona Q4 earnings miss estimates with a 10% sales drop, and the company forecasts lower 2025 sales.
Via Benzinga · February 27, 2025
Earnings Scheduled For February 27, 2025benzinga.com
Via Benzinga · February 27, 2025
Deep Dive Into Dentsply Sirona Stock: Analyst Perspectives (8 Ratings)benzinga.com
Via Benzinga · January 30, 2025
Forecasting The Future: 7 Analyst Projections For Dentsply Sironabenzinga.com
Via Benzinga · December 4, 2024
The Latest Analyst Ratings For Dentsply Sironabenzinga.com
Via Benzinga · October 28, 2024
Earnings To Watch: Dentsply Sirona (XRAY) Reports Q4 Results Tomorrow
Dental products company Dentsply Sirona (NASDAQXRAY) will be announcing earnings results tomorrow morning. Here’s what you need to know.
Via StockStory · February 26, 2025
This Analog Devices Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga.com
Via Benzinga · February 14, 2025
Apple To $280? Here Are 10 Top Analyst Forecasts For Thursdaybenzinga.com
Via Benzinga · January 23, 2025
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?benzinga.com
Patient Square Capital agrees to buy Patterson Companies for $4.1 billion. Analysts predict minimal regulatory hurdles and a strong bid unlikely to face competition.
Via Benzinga · December 12, 2024
Navigating 6 Analyst Ratings For Dentsply Sironabenzinga.com
Via Benzinga · October 8, 2024
Analyst Expectations For Dentsply Sirona's Futurebenzinga.com
Via Benzinga · September 20, 2024
A Glimpse Into The Expert Outlook On Dentsply Sirona Through 10 Analystsbenzinga.com
Via Benzinga · July 18, 2024
Evaluating Dentsply Sirona: Insights From 8 Financial Analystsbenzinga.com
Via Benzinga · June 25, 2024
10 Health Care Stocks With Whale Alerts In Today's Sessionbenzinga.com
Via Benzinga · December 10, 2024
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000benzinga.com
Via Benzinga · November 7, 2024
Gold Gains 1%; Halliburton Posts Weak Q3 Resultsbenzinga.com
Via Benzinga · November 7, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · November 7, 2024
Dentsply Sirona Stock Sinks On Dismal 2024 Guidance, Blames Macroeconomic, Competitive Pressures And Weakened Demandbenzinga.com
Dentsply Sirona Q3 earnings beat estimates, but a $495M goodwill impairment and lowered sales outlook cause stock to drop 22%.
Via Benzinga · November 7, 2024
Tesla To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Mondaybenzinga.com
Via Benzinga · October 28, 2024
Critical Insights From Dentsply Sirona Analyst Ratings: What You Need To Knowbenzinga.com
Via Benzinga · August 20, 2024
Dentsply Sirona Misses Q2 Targets - Plans Restructuring Plan Amid Weak Demandbenzinga.com
Dentsply Sirona misses Q2 earnings, announces restructuring amid weak demand.
Via Benzinga · July 31, 2024
XRAY Stock Earnings: Dentsply Sirona Misses EPS, Misses Revenue for Q2 2024investorplace.com
XRAY stock results show that Dentsply Sirona missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · July 31, 2024